Craig Sauter, MD | Cleveland Clinic

Dr. Craig Sauter, MD

Claim this profile

Memorial Sloan Kettering Cancer Center

Studies Lymphoma
Studies Mixed-Cell Lymphoma
9 reported clinical trials
20 drugs studied

Area of expertise

1Lymphoma
Craig Sauter, MD has run 5 trials for Lymphoma.
2Mixed-Cell Lymphoma
Craig Sauter, MD has run 4 trials for Mixed-Cell Lymphoma. Some of their research focus areas include:
CD19 positive
Philadelphia chromosome positive

Affiliated Hospitals

Image of trial facility.
Memorial Sloan Kettering Cancer Center
Image of trial facility.
Memorial Sloan Kettering Westchester

Clinical Trials Craig Sauter, MD is currently running

More about Craig Sauter, MD

Clinical Trial Related8 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Craig Sauter, MD has experience with
  • Etoposide
  • Autologous Hematopoietic Stem Cell Transplantation
  • Carmustine
  • Cytarabine
  • Melphalan
  • Lentivirus Vector CCR5 ShRNA/TRIM5alpha/TAR Decoy-transduced Autologous CD34-positive Hematopoietic Progenitor Cells

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Craig Sauter, MD specialize in?
Is Craig Sauter, MD currently recruiting for clinical trials?
Are there any treatments that Craig Sauter, MD has studied deeply?
What is the best way to schedule an appointment with Craig Sauter, MD?
What is the office address of Craig Sauter, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security